Abstract
The research is devoted to the substantiation of the necessity of innovative transformations of the value chain of pharmaceutical enterprises. The current state of the international pharmaceutical market and its development scenarios developed by the WTO were analyzed, taking into account the changes caused by the COVID-19 coronavirus pandemic. The typology of value chains is considered and their element-by-element characteristics are given. A new, modern model of interaction in the chain of value creation of products is proposed. The substantiation of efficiency of creation of such chains is given. Based on the correlation analysis, the presence of a linear relationship between the indicators of Pharmaceutical R&D Spend and Revenue was established. To maximize the effect of R&D costs, pharmaceutical companies are recommended to carry out innovative transformations of the value chain, involving external manufacturers of high-tech devices, applications, etc.
Highlights
ІННОВАЦІЙНІ ПЕРЕТВОРЕННЯ ЛАНЦЮГА СТВОРЕННЯ ЦІННОСТІ ФАРМАЦЕВТИЧНИХ ПІДПРИЄМСТВThe current state of the international pharmaceutical market and its development scenarios developed by the WTO were analyzed, taking into account the changes caused by the COVID-19 coronavirus pandemic
Копішинська Катерина Олександрівна кандидат економічних наук, доцент, Національний технічний університет України «Київський політехнічний інститут імені Ігоря Сікорського»
The current state of the international pharmaceutical market and its development scenarios developed by the WTO were analyzed, taking into account the changes caused by the COVID-19 coronavirus pandemic
Summary
The current state of the international pharmaceutical market and its development scenarios developed by the WTO were analyzed, taking into account the changes caused by the COVID-19 coronavirus pandemic. Для максимізації ефекту від витрат на НДДКР, фармацевтичним компаніям рекомендується здійснити інноваційні перетворення ланцюга створення цінності із залученням зовнішніх виробників високотехнологічних пристроїв, програм, що прискорить НДДКР, підвищить їх ефективність та сприятиме зменшенню витрат компаній на виробництво та випуск на ринок нових лікарських засобів та фармацевтичних товарів. The publications of these scientists cover current issues of investment and innovation development of the pharmaceutical industry of Ukraine, but many issues related to the development of the pharmaceutical market remain little researched and require in-depth study [2] This topic is widely studied at the international level, including by such international organizations as the WTO [3]. Percent changes of global real exports per sector under different scenarios in 2020
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
